Investments

Bone Biologics is focusing development of a bone graft substitute for bone regeneration in spinal fusion procedures, while additionally having...

Symani can support challenging and complex trauma procedures with an increased degree of precision and control in an optimized work...

Pixee closed a $15 million capital raising to accelerate commercialization in the U.S. and launch next-generation products. ...

While economic pressure slowed orthopedic funding in recent years, there is ample capital for enabling technology companies....

Funds will support clinical trials, regulatory filing and ex-U.S. commercialization of the company's artificial cervical disc....

icotec is commercializing BlackArmor Carbon/PEEK products that may offer significant clinical advantages over traditional metal implants in the context of...

These companies address unmet clinical needs in the medTech and robotics space, spanning indications such as orthopedics and spine surgery....

The infusion will support salesforce expansion in underpenetrated markets and accelerate clinical research and product development efforts....

Funds will support commercialization and new application development of the Bolt Navigation System for spine surgeries....

Orthopedic investors are prioritizing later-stage companies with a clear path to commercialization and profitability....